Boston Police ID suspect in connection with hospital lobby stabbing
The Boston Police Department has identified the suspect arrested in connection with the stabbing of a person in Massachusetts General Hospital's lobby.
John Huddleston, 56, of Boston, was arrested on Thursday and is expected to be arraigned in Boston Municipal Court on the charges of mayhem and assault and battery with a dangerous weapon, according to a Boston Police Department spokesperson.
At about 8:32 a.m., officers responded to a radio call for a person with a knife, the spokesperson said. While traveling to the hospital, the call was upgraded to a report of a stabbing. The officers were also provided with a description of the suspect.
When they arrived, the police located and apprehended the suspect, who was identified as Huddleston.
Additional members of the department entered the hospital and found an adult male victim receiving treatment for non-life-threatening stab wounds.
A crime scene was set up in the vestibule of the hospital's lobby, which is where the stabbing took place, the spokesperson told MassLive.
The victim's name was not given.
In a statement provided to MassLive, the hospital confirmed that the victim was treated and released.
'The hospital is safe, open, and operating normally,' the statement reads. 'We are grateful to our staff and Boston Police for their quick response in bringing this incident to a close.'
Stabbing takes place in Mass. General Hospital lobby in Boston
Giggity, giggity: 'Family Guy'-themed pop-up coming to Boston this summer
New outdoor restaurant brings modern Asian creations, cocktails to Somerville
Boston woman sentenced for identity theft in drug trafficking scheme
Boston shooting suspect didn't get a court-appointed attorney — and you might not either
Read the original article on MassLive.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
DMPD ends 30×30 initiative to comply with state law banning DEI
DES MOINES, Iowa — A bill signed by Governor Reynolds to remove DEI initiatives, policies, and programs is impacting law enforcement agencies in Des Moines, as the city announced it's withdrawing from a national initiative aimed at recruiting and retaining more women in law enforcement. To comply with House File 856, which was signed into law on May 27, Des Moines is eliminating its 30×30 program. A national initiative to improve and grow the representation of women in law enforcement. The Des Moines Police Department joined the initiative in late 2021, with the goal of growing women in police recruitment classes to 30% by 2030. The change comes just after the police department celebrated its most diverse class of recruits yet in 2024. Increasing the number of Asian, Black, and Hispanic officers and increasing bilingual officers on the force. Currently, the City of Des Moines said that the Des Moines Police Department has 43 sworn female officers, representing roughly 11% of sworn officers. Forecast: Mild temps and tiny rain chances City Manager Scott Sanders was unavailable for an on-camera interview on Wednesday, but did provide a list of answers to questions WHO 13 had about the change. When asked about the importance of diverse officers on the force to better serve the community, Sanders said, 'There are many important factors to our police department's success serving the Des Moines community. The top of that list is our officers and their passion for helping our residents and visitors. Whether responding to a call or building relationships in the community, it is our officers' collective goal to protect both lives and property for every member of our community to the best of their ability.' When asked about ensuring future law enforcement career opportunities are open to all individuals, Sanders said, 'The Des Moines police remains committed to providing an attractive workplace for all potential recruits, including women, as it also strives to be a welcoming employer to all officers who are qualified and dedicated to serving the Des Moines community.' When asked about the 30×30 initiative and the decision to withdraw, Sanders said, 'The DMPD's participation in the 30×30 initiative was a goal to increase the presence of women in the Des Moines Police Department. The discontinuation of the 30×30 program means that there will no longer be a hiring goal for the number of women hired by Des Moines Police to comply with state law.' Metro News: DMPS selling student-run radio station KDPS 88.1 FM DMPD ends 30×30 initiative to comply with state law banning DEI 'Suspicious package' found near Federal Building shuts down downtown DSM road Hundreds of volunteers needed for National Speech and Debate Tournament in Des Moines Des Moines man guilty of fatally shooting man at hotel sentenced to prison Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Miami Herald
6 hours ago
- Miami Herald
Vietnam Ends Two-Child Policy to Tackle Falling Birth Rates
Vietnam has abolished its long-standing two-child policy to tackle concerns about declining birth and fertility rates. The National Assembly Standing Committee approved a new regulation lifting the restriction, permitting couples to freely choose the timing, number, and spacing of their children on Tuesday, state media reports. The fertility rate in Vietnam, Southeast Asia's third-most-populous nation, has fallen to 1.91 births per woman in 2024, according to the Vietnam General Statistics Office. This is well below the replacement threshold of 2.1 needed to maintain the population size. Vietnam introduced its two-child policy in 1988 to curb rapid population growth, when the average woman had more than four children. The law restricted most families to one or two children, with exceptions in special cases. Enforcement was stricter for Communist Party members, who faced penalties including warnings, reduced bonuses, or dismissal from positions for violations. Vietnam's decision to scrap its two-child policy followed a steady decrease in birth rates since 2022, when the fertility rate dropped to 2.01 and declined again to 1.93 in 2023. Health officials have expressed concern that the nation's population of nearly 100 million may begin to contract by mid-century. Authorities have also cited gender imbalances and the ongoing shift toward a "super-aged society," with projections that over 20 percent of Vietnamese will be age 65 or older by 2049. Under the new regulation, all families-regardless of Party membership-can now choose freely how many children to have and when. Vietnam's policy shift aligns with recent moves in other Asian countries also experiencing plunging fertility rates and rapid aging. China saw a slight uptick in its birth rate in 2024, attributed mainly to cultural factors such as the Year of the Dragon, despite wide-ranging pro-natal measures and the end of restrictive family policies. Meanwhile, the country's overall population has continued to shrink for the third consecutive year. Japan, facing a decades-long population decline and with nearly 30 percent of its population over age 65, is preparing to make childbirth free as early as April 2026. The Japanese government proposes that public health insurance cover all delivery costs nationwide, attempting to alleviate financial burdens on families. The United Nations Population Fund says: "Vietnam is in the period of population aging. The process of population aging is progressing rapidly, caused by mortality and fertility declines, and life expectancy at birth increase and that transition from an 'aging' to an 'aged' population will occur within just 20 years." The Vietnamese Ministry of Health is expected to submit a new population law to the National Assembly in 2025, aimed at sustaining fertility rates near replacement level while monitoring the ongoing demographic transition and the effects of the relaxed family planning rules. Related Articles Trump Business Booms Abroad Amid Ethics QuestionsUS Warship Challenged Beijing's South China Sea Claims, Navy SaysFull List of Trump's Foreign Real Estate Ventures Underway Around the WorldVideo Shows Moment Emmanuel Macron Pushed in Face by Wife 2025 NEWSWEEK DIGITAL LLC.
Business Wire
8 hours ago
- Business Wire
Elucidata and Sapien Biosciences Announce Strategic Partnership to Transform Biobank Assets into high quality AI Products
SAN FRANCISCO & HYDERABAD, India--(BUSINESS WIRE)--Elucidata, a leader in data-centric AI for drug discovery and translational research, and Sapien Biosciences, India's first and largest commercial biobank with 300,000+ patient samples founded in partnership with Apollo Hospitals, today announced a strategic partnership to convert Sapien's extensive biobank assets into AI-ready, multimodal data products for use in drug and diagnostic development. Through this collaboration, Sapien will harness Elucidata's platform to integrate, standardize, and enrich its vast repository of biospecimens and curated clinical data, making them accessible for predictive modeling, synthetic data generation, and advanced genomics research. The partnership reflects a shared focus on turning real-world patient data into high-value actionable insights that drive precision medicine and improve outcomes worldwide. With access to over 300,000 patient samples across oncology, cardiology, autoimmune, inflammation, neurology, and other diseases, Sapien operates at a scale matched by few biobanks worldwide. This includes more than 85,000 cancer patients, increasingly paired with digitized histopathology images, genomic profiles, and structured longitudinal clinical data, making it one of the top 10 biobanks globally and the largest integrated resource for Asian patient data. 'At Sapien, we believe that deeply characterized patient data especially from underrepresented populations like those in India can catalyze more inclusive and effective diagnostics and therapies worldwide,' said Dr. Jugnu Jain, CEO and Co-founder of Sapien Biosciences. 'This partnership with Elucidata enables us to convert our rich biological and clinical datasets into interoperable, AI-ready formats, unlocking their potential for translational research, patient stratification, and precision drug development.' The first phase of the collaboration will focus on building AI models that infer genomic and transcriptomic insights from digital pathology images. By using NGS-annotated slides from Sapien's cancer biobank, the project will enable the generation of synthetic multi-modal datasets essential for next-generation diagnostic tools and tissue-sparing research strategies. This is particularly valuable for rare cancers and limited biopsy specimens. 'Sapien's scale, sample quality, and data depth make it a critical partner in our mission to democratize access to high quality, AI-ready biomedical data,' said Dr. Abhishek Jha, CEO and Co-founder of Elucidata. 'By applying our Polly platform to Sapien's datasets, we can bridge the gap between fragmented sample collections and next-gen AI models that accelerate target discovery and biomarker validation.' In addition to oncology, the partnership will explore multi-disease use cases across Sapien's biobank, including cardiovascular, autoimmune, and neurological disorders, building synthetic clinicogenomic datasets that support pharma R&D and companion diagnostic development. 'This partnership between Elucidata and Sapien Biosciences brings together Sapien's extensive, high-quality biobank resources and Elucidata's expertise in AI-powered data integration. By making rich biospecimens and clinical datasets AI-ready, this collaboration has the potential to accelerate global innovation and help reduce the complexity of human biology for research and patient care,' said Dr. Navjot Singh, advisor of and healthcare leader with 22 years of expertise in strategy, technology, and innovation, most recently as a Senior Partner at McKinsey & Company. Elucidata recently ranked 7th in the Broad Institute's Autoimmune Disease Machine Learning Challenge and recently won the National Cancer Institute's Cancer Research Data Commons AI Data Readiness Challenge, highlighting its leadership in data-centric AI for life sciences. About Elucidata Elucidata is a data-first AI company that accelerates life sciences R&D by converting fragmented biomedical datasets into harmonized, AI-ready assets. Its proprietary Polly platform integrates EHRs, genomics, imaging, and clinical trial data for seamless downstream analysis and model development. Headquartered in San Francisco with offices across the U.S. and India, Elucidata supports over 70 pharma and diagnostics clients, and has contributed to 16 drug programs progressing toward FDA approvals. Recognized by the National Cancer Institute and Fast Company for its innovation in biotech, Elucidata is enabling a new era of data-driven discovery. Visit for more information. About Sapien Biosciences Founded in partnership with Apollo Hospitals, Sapien Biosciences is India's premier multi-disease biobank and a leader in Indian real-world evidence (RWE) for personalized medicine. With access to more than 300,000 patients' samples including 2 million pathology samples, Sapien offers FFPE tissues, blood, and liquid biopsy samples along with annotated histopathology slides and longitudinal clinical data. Its resources support a broad range of applications from AI/ML modeling and multi-omics research to drug screening in patient tumor-derived cells and biomarker discovery. Sapien has published over 10 peer-reviewed studies using Indian patient data and collaborates with leading diagnostic and pharma companies to reduce the representation gap in global omics datasets. Learn more at
